LB Pharmaceuticals (LBRX) Balance Sheet: Assets & Liabilities

LB Pharmaceuticals (LBRX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), LB Pharmaceuticals reported total assets of $312.93M and total liabilities of $11.62M. Shareholders' equity was $301.31M. Total debt stood at $3.57M against $295.21M in cash and short-term investments, a net cash position of $291.64M. That puts debt-to-equity at 0.01.

LB Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for LB Pharmaceuticals Inc (LBRX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	250.17	22.98	14.98	21.40
Short-Term Investments	45.04	5.02	28.31	0.00
Cash & Short-Term Investments	295.21	28.00	43.29	21.40
Accounts Receivable	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	13.22	0.88	0.02	0.01
Total Current Assets	308.43	28.88	45.63	21.49
Non-Current Assets
Property, Plant & Equipment (Net)	3.73	4.16	0.02	0.00
Long-Term Investments	0.77	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.50	0.00	0.00
Total Non-Current Assets	4.50	4.66	0.02	0.00
Total Assets	312.93	33.53	45.66	21.49
Current Liabilities
Accounts Payable	2.13	2.32	1.39	0.16
Short-Term Debt	0.73	0.49	0.00	0.00
Accrued Liabilities	2.39	3.06	0.42	0.09
Other Current Liabilities	4.59	5.30	1.22	0.31
Total Current Liabilities	7.44	8.11	2.61	0.47
Non-Current Liabilities
Long-Term Debt	2.84	3.22	0.00	24.15
Other Non-Current Liabilities	1.34	116.76	77.52	18.49
Total Non-Current Liabilities	4.18	119.98	77.52	49.84
Total Liabilities	11.62	128.09	80.13	50.30
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00
Retained Earnings	-129.53	-104.32	-41.22	-34.95
Accumulated Other Comprehensive Income	0.17	0.11	0.27	0.00
Additional Paid-in Capital	430.67	9.66	6.47	6.13
Shares Outstanding	25.30	22.44	22.44	22.44
Total Stockholders' Equity	301.31	-94.55	-34.47	-28.81
Total Liabilities & Equity	312.93	33.53	45.66	21.49

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About LB Pharmaceuticals Balance Sheet

How much debt does LB Pharmaceuticals have?

LB Pharmaceuticals had total debt of $3.57M as of Dec 31, 2025, against $295.21M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $3.70M a year earlier.

What are LB Pharmaceuticals's total assets?

LB Pharmaceuticals reported total assets of $312.93M as of Dec 31, 2025, up 833.2% from $33.53M a year earlier. Total liabilities were $11.62M.

What is LB Pharmaceuticals's shareholders' equity?

LB Pharmaceuticals's shareholders' equity was $301.31M as of Dec 31, 2025, or about $11.91 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition